Rapid assessment of SARS-CoV-2–evolved variants using virus-like particles AM Syed, TY Taha, T Tabata, IP Chen, A Ciling, MM Khalid, B Sreekumar, ... Science 374 (6575), 1626-1632, 2021 | 174 | 2021 |
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination RK Suryawanshi, IP Chen, T Ma, AM Syed, N Brazer, P Saldhi, ... Nature 607 (7918), 351-355, 2022 | 144 | 2022 |
Therapeutic ligands antagonize estrogen receptor function by impairing its mobility J Guan, W Zhou, M Hafner, RA Blake, C Chalouni, IP Chen, T De Bruyn, ... Cell 178 (4), 949-963. e18, 2019 | 122 | 2019 |
Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles AM Syed, A Ciling, TY Taha, IP Chen, MM Khalid, B Sreekumar, PY Chen, ... Proceedings of the National Academy of Sciences 119 (31), e2200592119, 2022 | 112 | 2022 |
SIRT5 is a proviral factor that interacts with SARS-CoV-2 Nsp14 protein M Walter, IP Chen, A Vallejo-Gracia, IJ Kim, O Bielska, VL Lam, ... PLoS Pathogens 18 (9), e1010811, 2022 | 16 | 2022 |
FOXO1 promotes HIV latency by suppressing ER stress in T cells A Vallejo-Gracia, IP Chen, R Perrone, E Besnard, D Boehm, E Battivelli, ... Nature microbiology 5 (9), 1144-1157, 2020 | 12 | 2020 |
Viral E protein neutralizes BET protein-mediated post-entry antagonism of SARS-CoV-2 IP Chen, JE Longbotham, S McMahon, RK Suryawanshi, MM Khalid, ... Cell reports 40 (3), 2022 | 11 | 2022 |
Limited cross-variant immunity after infection with the SARS-CoV-2 Omicron variant without vaccination. medRxiv 2022 RK Suryawanshi, IP Chen, T Ma, AM Syed, N Brazer, P Saldhi, ... Google Scholar, 0 | 8 | |
Rapid assembly of SARS-CoV-2 genomes reveals attenuation of the Omicron BA. 1 variant through NSP6 TY Taha, IP Chen, JM Hayashi, T Tabata, K Walcott, GR Kimmerly, ... Nature Communications 14 (1), 2308, 2023 | 4 | 2023 |
Viral Hijacking of BET Proteins IP Chen, M Ott Viruses 14 (10), 2274, 2022 | 2 | 2022 |
Abstract NG05: Not all “SERDs” are equal: Context-independent ER degradation and full ER antagonism define the next generation of ER therapeutics J Guan, W Zhou, A Daemen, SJ Hartman, RA Blake, A Heidersbach, M Yu, ... Cancer Research 78 (13_Supplement), NG05-NG05, 2018 | 2 | 2018 |
SARS-CoV-2 protein ORF8 limits expression levels of Spike antigen and facilitates immune evasion of infected host cells IJ Kim, Y Lee, MM Khalid, IP Chen, Y Zhang, M Ott, E Verdin Journal of Biological Chemistry, 104955, 2023 | 1 | 2023 |
Mild SARS-CoV-2 infection results in long-lasting microbiota instability V Upadhyay, RK Suryawanshi, P Tasoff, M McCavitt-Malvido, RG Kumar, ... mBio, e00889-23, 2023 | 1 | 2023 |
A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication and pathogenesis in vivo TY Taha, RK Suryawanshi, IP Chen, GJ Correy, PC O’Leary, ... bioRxiv, 2023.04. 18.537104, 2023 | 1 | 2023 |
Abstract GS3-05: Prospective optimization of estrogen receptor degradation yields ER ligands with variable capacities for ER transcriptional suppression C Metcalfe, W Zhou, J Guan, A Daemen, M Hafner, RA Blake, E Ingalla, ... Cancer Research 79 (4_Supplement), GS3-05-GS3-05, 2019 | 1 | 2019 |
NAPE-PLD regulates specific baseline affective behaviors but is dispensable for inflammatory hyperalgesia I Chen, LB Murdaugh, C Miliano, Y Dong, AM Gregus, MW Buczynski Neurobiology of Pain 14, 100135, 2023 | | 2023 |
SARS-CoV-2 Evolution Balances Conflicting Roles of N Protein Phosphorylation AM Syed, A Ciling, IP Chen, CR Carlson, A Adly, H Martin, TY Taha, ... | | 2023 |
Post-acute immunological and behavioral sequelae in mice after Omicron infection T Ma, RK Suryawanshi, SR Miller, KK Ly, R Thomas, N Elphick, K Yin, ... bioRxiv, 2023.06. 05.543758, 2023 | | 2023 |
Deciphering Host Immune Responses to SARS-CoV-2 Infection I Chen University of California, San Francisco, 2023 | | 2023 |
Rapid assembly of SARS-CoV-2 genomes reveals attenuation of the Omicron BA. 1 variant through NSP6 (preprint) TY Taha, IP Chen, JM Hayashi, T Tabata, K Walcott, GR Kimmerly, ... | | 2023 |